Kroger's E-Commerce Grows 20% as Pharmacy Drags Guidance

Kroger reported 5% adjusted earnings-per-share growth and 20% e-commerce growth in its fiscal second quarter of 2026 while trimming its full-year identical sales guidance, citing pharmacy headwinds and a Cyclospora outbreak; the shares last closed at 58.49, up 2.70%.

Kroger (KR) used its fiscal second-quarter 2026 earnings call to tell investors two things at once: the parts of the business it has spent years building — digital ordering and the advertising arm that rides on it — are compounding nicely, and the parts it controls least, pharmacy economics and food safety, are enough to force the full-year sales outlook lower.

The grocer posted 5% adjusted earnings-per-share growth and 20% growth in e-commerce, according to the company's second-quarter call, while trimming its full-year identical sales guidance. Management pointed to pharmacy headwinds and a Cyclospora outbreak as the drags. Shares last closed at 58.49, up 2.70% on the session, with a day range of 55.65 to 59.49 against a prior close of 56.95 — a wide intraday swing that suggests the market spent the day arguing with itself about which half of the story mattered more.

Why a guidance trim lands harder than an EPS beat

Identical sales — sales at stores open long enough to be comparable, stripped of new openings and closures — is the number grocery investors watch before anything else. It is the cleanest read on whether a chain is winning or losing shoppers. Adjusted EPS can be helped by buybacks, cost programs and one-time exclusions; identical sales cannot.

So a quarter that delivers 5% adjusted EPS growth alongside a lower identical sales range creates a familiar tension. Earnings quality looks fine. The top-line trajectory looks softer than it did a quarter ago. In a business with thin margins and enormous volume, the top line is the lever that eventually determines everything else, which is why a trim of any size gets more attention than the profit line that came in on plan.

The reasons Kroger gave matter for how investors should read it. Neither pharmacy pressure nor a Cyclospora outbreak is a statement about whether shoppers are choosing Kroger over a rival. That is the bull case: the cut is composition, not share loss. The bear case is that pharmacy headwinds have a way of persisting across multiple quarters rather than reversing on their own.

Pharmacy: high sales dollars, low margin dollars

Pharmacy is an unusual line inside a supermarket. It carries large revenue per transaction — a single specialty prescription can dwarf an entire grocery basket — but the margin on those dollars is compressed by reimbursement rates set by pharmacy benefit managers and insurers, not by the retailer. When the mix shifts toward higher-priced, lower-margin drugs, sales can look healthy while gross profit does not follow.

That is why pharmacy shows up in a guidance discussion as a headwind rather than as a growth story. It also explains why grocers keep the counters open anyway: the pharmacy is a traffic anchor, and the customer who collects a prescription tends to fill a cart on the way out. The strategic question is whether that halo still justifies the margin drag, and Kroger's citing of pharmacy in its revised outlook puts the question squarely in front of shareholders.

The Cyclospora hit is a cost with a clock on it

Cyclospora is a parasite spread through contaminated food and water, most often associated with fresh produce, and it triggers recalls, product destruction and lost shelf space in the fresh departments that anchor a grocery store's reputation. An outbreak cited on an earnings call is, in accounting terms, a discrete event: the affected product is pulled, the sales are lost, and the comparison eventually laps.

The wider cost is harder to quantify and is not disclosed as a number. Fresh produce is where supermarkets compete for the shopper who would otherwise go to a specialty grocer, and trust in that department is slow to rebuild. Investors should treat the sales effect as a defined-period item and the reputational effect as the open question.

Digital and retail media are the margin offset

Against those drags, 20% e-commerce growth is the number that gives management its argument. Online grocery has historically been a margin problem for the industry — picking, packing and delivering a basket of low-priced, perishable items costs real money — but the economics improve materially at scale, and they improve again when the digital platform becomes an advertising business.

That is the retail media story. When a shopper searches for a product on a grocer's app, the placement of the results is inventory the brand can pay for. Those dollars carry margins closer to a media company's than to a supermarket's, and they land in the same profit pool that pharmacy reimbursement is eroding. The more e-commerce volume Kroger pushes through, the more advertising inventory it has to sell — which makes the 20% figure a leading indicator for the higher-margin line, not just a channel statistic.

The call highlights were summarized by GuruFocus, which framed the quarter as a disciplined-consumer story — shoppers still spending, but trading carefully.

Where the stock sat going in

The last traded price of 58.49 came on a broadly firm tape. The S&P 500 tracker closed at $764.29, up 0.85%, the Nasdaq 100 tracker at $714.88, up 0.87%, and the Dow tracker at $525.79, up 0.97%, all as of the close on Friday, 11 September 2026. Kroger's 2.70% gain outpaced each of those benchmarks on the day, though the low end of its range sat beneath the prior close — a session that traded on both sides before finishing higher.

Defensive grocery names tend to attract flows when investors are wary of cyclical exposure, and a chain whose profit engine is shifting toward advertising sits awkwardly between staples and media in most screens. That ambiguity can work both ways depending on which narrative the market is paying for at the time.

What to track from here

The composition of the identical sales trim. How much of the reduction is pharmacy versus fresh recovery determines whether it laps or lingers.
Retail media disclosure. The more granular Kroger gets about advertising revenue and its margin, the easier it becomes for the market to value that piece separately from grocery.
E-commerce profitability, not just growth. A 20% growth rate is only a positive if the incremental basket contributes profit.
Fresh department trends post-outbreak. Produce volumes are the clearest signal of whether shopper trust returned.
Reimbursement commentary. Any change in pharmacy benefit terms flows straight through to the grocery margin line.

The shape of the quarter is legible enough: Kroger is earning more per share while selling slightly less than it planned to, and it is funding the gap with a digital advertising business that did not exist at meaningful scale a decade ago. Whether that trade holds through the back half depends on issues — drug reimbursement and food safety — that no amount of app engagement can offset.

Key facts

KR last close: 58.49, +2.70% (as of Fri, 11 Sep 2026, 20:00 GMT)
Adjusted EPS growth: 5% in fiscal Q2 2026
E-commerce growth: 20% year over year
Full-year guidance: Identical sales outlook trimmed on pharmacy and Cyclospora impacts

Frequently asked questions

What did Kroger report in its fiscal second quarter of 2026?

Kroger reported 5% adjusted earnings-per-share growth and 20% growth in e-commerce for its fiscal second quarter of 2026. On the same earnings call, the company trimmed its full-year identical sales guidance, citing pharmacy headwinds and a Cyclospora outbreak as the two drags on its revised outlook.

Why did Kroger cut its identical sales guidance?

Management pointed to two causes: pharmacy headwinds and a Cyclospora outbreak. Pharmacy revenue carries low margins set by reimbursement rates outside the retailer's control, while the Cyclospora outbreak triggered product withdrawals in fresh categories. Neither reason reflects shoppers switching to competing grocery chains, though pharmacy pressure tends to persist across quarters.

What are identical sales and why do grocery investors watch them?

Identical sales measure revenue at stores open long enough to be compared year over year, excluding new openings and closures. They are the cleanest read on whether a chain is gaining or losing customers, because unlike adjusted earnings per share they cannot be flattered by buybacks, cost programs or one-time exclusions.

How does retail media fit into Kroger's results?

Retail media is advertising sold on a retailer's own digital properties, such as sponsored placements when a shopper searches in the grocery app. Those revenues carry much higher margins than selling groceries. Because the inventory grows with digital order volume, Kroger's 20% e-commerce growth also expands the advertising business behind it.

Where did Kroger shares last trade?

KR last closed at 58.49, a gain of 2.70% from a prior close of 56.95, with an intraday range of 55.65 to 59.49, as of the close on Friday, 11 September 2026. That gain exceeded the S&P 500, Nasdaq 100 and Dow trackers, which rose 0.85%, 0.87% and 0.97% respectively on the same session.

What is Cyclospora and why does it affect a grocer?

Cyclospora is a parasite transmitted through contaminated food and water, commonly linked to fresh produce. An outbreak forces recalls, product destruction and lost shelf space in fresh departments. The direct sales effect is a defined-period item that eventually laps, but the harder cost is rebuilding shopper trust in produce.

Sources

The Kroger Co (KR) (Q2 2026) Earnings Call Highlights: E-Commerce and Retail Media Shine as ... — GuruFocus

Photo: Gustavo Fring · Pexels Licence — source